Veterinary Medicines

Synulox Ready-To-Use, 140 mg/ml + 35 mg/ml, suspension injectable pour chiens et chats

Authorised
  • Amoxicillin
  • Clavulanic acid
Download as PDF

Product identification

Medicine name:
Synulox Ready-To-Use, 140 mg/ml + 35 mg/ml, suspension injectable pour chiens et chats
Synulox Ready-To-Use 140 mg/ml Injektionssuspension
Active substance:
  • Amoxicillin
  • Clavulanic acid
Target species:
  • Dog
  • Cat
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Amoxicillin
    140.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Clavulanic acid
    35.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01CR02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Luxembourg
Package description:
  • Synulox Ready-To-Use 10 ml Vial Suspension for injection
  • Synulox Ready-To-Use 20 ml Vial Suspension for injection
  • Synulox Ready-To-Use 50 ml Vial Suspension for injection
  • Synulox Ready-To-Use 100 ml Vial Suspension for injection
  • Synulox Ready-To-Use 12 10 ml Vial Suspension for injection
  • Synulox Ready-To-Use 12 20 ml Vial Suspension for injection
  • Synulox Ready-To-Use 12 50 ml Vial Suspension for injection

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Zoetis Belgium
Marketing authorisation date:
Manufacturing sites for batch release:
  • Haupt Pharma Latina S.r.l.
Responsible authority:
  • Ministry Of Health And Social Security
Authorisation number:
  • V 087/97/04/0455
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 16/03/2023
Download